Top Markets
Coin of the day
Xspray Pharma AB (publ) Xspray Pharma AB (publ)

Xspray Pharma AB (publ)

XSPRAY
Rang in Aktien #24889
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden,... Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
Aktienkurs
$1.18
Marktkapitalisierung
$55.82M
Veränderung (1 Tag)
1.35%
Veränderung (1 Jahr)
-73.35%
Land
SE
Handel Xspray Pharma AB (publ) (XSPRAY)

Kategorie

Dividendenrendite-Verlauf für Xspray Pharma AB (publ) (XSPRAY)
Dividendenrendite (TTM) von Xspray Pharma AB (publ) (Aktienkürzel: XSPRAY) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Xspray Pharma AB (publ) (XSPRAY) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.00%
US